Evoke (EVOK) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
8 Jun, 2026Opening remarks and agenda
Chair welcomed shareholders, introduced board and executive team, and acknowledged the recommended acquisition by Bally's Intralot.
Meeting was declared open with a quorum present, and formal notice of resolutions was given.
Board and executive committee updates
Chair highlighted his recent appointment and the presence of both non-executive and executive directors.
Shareholder proposals
Sixteen resolutions were set out in the notice of meeting, with voting to be conducted via poll.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Evoke
- Revenue and EBITDA rose, margins improved, and leverage fell amid strategic review and UK duty headwinds.EVOK
H2 202530 Apr 2026 - H1 lagged plans, but cost savings and new products set up 5%-9% H2 growth and margin recovery.EVOKTrading Update3 Feb 2026
- Revenue down, losses widen, but transformation and H2 margin recovery on track.EVOKH1 20241 Feb 2026
- FY25 revenue up 2%, EBITDA up 14-15%, with a strategic review amid UK tax hikes.EVOKQ4 2025 TU27 Jan 2026
- Growth resumed in 2024 with rising margins, strong core markets, and a clear deleveraging plan.EVOKH2 202426 Dec 2025
- Business transformation, renewed growth, and enhanced governance were key AGM themes.EVOKAGM 202527 Nov 2025
- Strong revenue and EBITDA growth, improved margins, and significant deleveraging achieved.EVOKH1 202523 Nov 2025
- Revenue up 5% in Q3 2025, all divisions grew, and FY25 EBITDA margin guidance reaffirmed.EVOKQ3 2025 TU28 Oct 2025
- Q2 revenue up 5% and Adjusted EBITDA up 43% year-over-year, with FY25 guidance reaffirmed.EVOKH1 2025 TU22 Jul 2025